LBO — ST. CHARLES MED CTR - PRINEVILLE
IRR: 18.6% | MOIC: 2.35x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.6%
IRR
2.35x
MOIC
$51.4M
Entry EV
$83.7M
Exit EV
$26.5M
Equity Invested
Sources & Uses
S&UTotal · $51.4M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $20.0M | 38.8% | |
| Sub Debt | $5.0M | 9.7% | |
| Equity | $26.5M | 51.5% | |
| Enterprise Value | $49.9M | 97.1% | |
| Transaction Fees | $1.5M | 2.9% | |
| Total Uses | $51.4M | 100.0% |
Interpretation
INTAt 2.35x MOIC and 18.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $8.0M |
| Exit Ev | $83.7M |
| Net Debt At Exit | $21.6M |
| Equity At Exit | $62.1M |
| Equity Invested | $26.5M |
| Total Value Created | $35.6M |
| Value From Growth | $31.3M |
| Value From Multiple | $2.5M |
| Value From Deleveraging | $3.4M |